SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : AVIGEN(avgn)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Tom M who wrote (34)5/29/1997 1:19:00 PM
From: Czechsinthemail   of 228
 
Tom,

Thanks for the reply. I'd have to say a move to 12 in the next three months is pretty optimistic! Clearly the price action on this company has been awful, but it hasn't been great for many of the small biotechs. Certainly insider buying of the stock would be nice, but what I'm trying to get a feel for is whether management has the right stuff to make this company work. I think the science looks good, but I'm not sure they have the cost-consciousness to conserve and utilize resources well. I'd say the jury is still out on that. Some companies have visionary management deeply committed to having the company succeed no matter what. Others don't.
My guess is that this company is probably at or near bottom, so the downside risk seems relatively slight compared with the upside potential. And the small capitalization means almost any good news, especially a partnership, could really give the stock a major bounce. I'm in it in a modest way, willing to test the waters and see what this company and its management are made of. Let's hope they can figure a way of taking the company and its stock on a more positive ride.

Baird
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext